# Summit Biolabs, Inc. — Form D

Summit Biolabs, Inc. of AURORA, CO, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-20. The offering totals $12.0M, of which $235K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2020-08-20
- Form: D
- Accession: 0001814370-20-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $235K
- Remaining: $11.8M
- Investors: 5
- Date of first sale: 2020-08-19
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-373631

## Issuer

- Name: Summit Biolabs, Inc.
- CIK: 0001814370
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 12635 E. MONTVIEW BLVD., AURORA, CO, 80045
- Phone: 3037868310

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Robert E Blomqust | Director | AURORA, CO |
| Shi-Long E Lu | Director | AURORA, CO |
| Robert E Blomqust | Executive Officer | AURORA, CO |
| Shi-Long E Lu | Executive Officer | AURORA, CO |

## More

- [CIK 1814370 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1814370&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001814370-20-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.